Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Pre-market Movers » 09:03
08/11/23
08/11
09:03
08/11/23
09:03
SPCE

Virgin Galactic

$3.25 /

-0.145 (-4.28%)

, SHCO

Soho House

$6.17 /

-0.01 (-0.16%)

, BDTX

Black Diamond Therapeutics

$3.40 /

+0.075 (+2.26%)

, MBRX

Moleculin Biotech

/

+

, ASLN

Aslan Pharmaceuticals

$2.08 /

-0.06 (-2.80%)

, ORGS

Orgenesis

$1.00 /

-0.001 (-0.10%)

, BFRI

Biofrontera Inc.

$11.01 /

-0.2 (-1.78%)

, AGLE

Aeglea BioTherapeutics

/

+

, ACST

Acasti Pharma

$2.43 /

+0.03 (+1.25%)

, HCWB

HCW Biologics

$2.01 /

+0.01 (+0.50%)

, CANO

Cano Health

$1.53 /

-0.02 (-1.29%)

Check out this morning's…

Earnings
Aslan Pharmaceuticals reports Q2 EPS (11c) vs (93c) last year » 07:05
08/11/23
08/11
07:05
08/11/23
07:05
ASLN

Aslan Pharmaceuticals

$2.08 /

-0.06 (-2.80%)

Reports Q2 revenue $12M…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Aslan says Eblasakimab met primary endpoint in Phase 2b dose-ranging study » 08:01
07/06/23
07/06
08:01
07/06/23
08:01
ASLN

Aslan Pharmaceuticals

$3.76 /

+0.01 (+0.27%)

ASLAN Pharmaceuticals…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Over a quarter ago
Hot Stocks
Aslan Pharmaceuticals announces publication on eblasakimab » 07:01
06/23/23
06/23
07:01
06/23/23
07:01
ASLN

Aslan Pharmaceuticals

$3.84 /

-0.16 (-4.00%)

ASLAN Pharmaceuticals…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Aslan Pharmaceuticals enters strategic licensing deal with Zenyaku Kogyo » 07:34
06/22/23
06/22
07:34
06/22/23
07:34
ASLN

Aslan Pharmaceuticals

$3.93 /

-0.225 (-5.42%)

ASLAN Pharmaceuticals and…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Conference/Events
Aslan Pharmaceuticals management to meet with Piper Sandler » 06:14
05/31/23
05/31
06:14
05/31/23
06:14
ASLN

Aslan Pharmaceuticals

$3.70 /

-0.23 (-5.85%)

Meeting to be held in New…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Initiation
Aslan Pharmaceuticals initiated with a Buy at Roth MKM » 16:36
05/30/23
05/30
16:36
05/30/23
16:36
ASLN

Aslan Pharmaceuticals

$3.70 /

-0.23 (-5.85%)

Roth MKM initiated…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Aslan Pharmaceuticals doses first patient in Phase 2a trial of farudodstat » 07:15
05/18/23
05/18
07:15
05/18/23
07:15
ASLN

Aslan Pharmaceuticals

$4.43 /

+0.07 (+1.61%)

ASLAN Pharmaceuticals…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Aslan Pharmaceuticals presents new data on Eblasakimab, Farudodstat » 07:33
05/15/23
05/15
07:33
05/15/23
07:33
ASLN

Aslan Pharmaceuticals

$4.28 /

-0.4 (-8.55%)

ASLAN Pharmaceuticals…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Recommendations
Aslan Pharmaceuticals price target lowered to $17 from $20 at H.C. Wainwright » 09:01
04/28/23
04/28
09:01
04/28/23
09:01
ASLN

Aslan Pharmaceuticals

$4.28 /

+0.04 (+0.94%)

H.C. Wainwright analyst…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.